178 related articles for article (PubMed ID: 19420170)
21. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
Tiwari HK; Sen MR
BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
[TBL] [Abstract][Full Text] [Related]
22. Novel screening agar for detection of vancomycin-nonsusceptible Staphylococcus aureus.
Burnham CA; Weber CJ; Dunne WM
J Clin Microbiol; 2010 Mar; 48(3):949-51. PubMed ID: 20089765
[TBL] [Abstract][Full Text] [Related]
23. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
[TBL] [Abstract][Full Text] [Related]
24. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.
Mirza HC; Sancak B; Gür D
Microb Drug Resist; 2015 Oct; 21(5):537-44. PubMed ID: 25919019
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of the performance of the MicroScan Pos Breakpoint Combo Panel Type 28 for susceptibility testing of Staphylococcus aureus: low-range minimum inhibitory concentration of vancomycin, cefoxitin screening, and inducible clindamycin resistance detection].
Ji M; Lee M; Noh S; Kim MN
Korean J Lab Med; 2010 Dec; 30(6):637-46. PubMed ID: 21157151
[TBL] [Abstract][Full Text] [Related]
26. Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway.
Kulah C; Aktas E; Comert F; Ozlu N; Akyar I; Ankarali H
BMC Infect Dis; 2009 Mar; 9():30. PubMed ID: 19291298
[TBL] [Abstract][Full Text] [Related]
27. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.
Tenover FC; Moellering RC
Clin Infect Dis; 2007 May; 44(9):1208-15. PubMed ID: 17407040
[TBL] [Abstract][Full Text] [Related]
28. Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals.
Hubert SK; Mohammed JM; Fridkin SK; Gaynes RP; McGowan JE; Tenover FC
J Clin Microbiol; 1999 Nov; 37(11):3590-3. PubMed ID: 10523558
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.
Walsh TR; Bolmström A; Qwärnström A; Ho P; Wootton M; Howe RA; MacGowan AP; Diekema D
J Clin Microbiol; 2001 Jul; 39(7):2439-44. PubMed ID: 11427551
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of disc diffusion methods and Vitek 2 automated system for testing susceptibility to mupirocin in Staphylococcus aureus.
Malaviolle X; Nonhoff C; Denis O; Rottiers S; Struelens MJ
J Antimicrob Chemother; 2008 Nov; 62(5):1018-23. PubMed ID: 18765413
[TBL] [Abstract][Full Text] [Related]
31. Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains with conventional and commercial testing systems.
Aldridge KE; Janney A; Sanders CV; Marier RL
J Clin Microbiol; 1983 Nov; 18(5):1226-36. PubMed ID: 6605976
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci.
Tenover FC; Williams PP; Stocker S; Thompson A; Clark LA; Limbago B; Carey RB; Poppe SM; Shinabarger D; McGowan JE
J Clin Microbiol; 2007 Sep; 45(9):2917-22. PubMed ID: 17634301
[TBL] [Abstract][Full Text] [Related]
33. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
Franchi D; Climo MW; Wong AH; Edmond MB; Wenzel RP
Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.
Hussain FM; Boyle-Vavra S; Shete PB; Daum RS
J Infect Dis; 2002 Sep; 186(5):661-7. PubMed ID: 12195353
[TBL] [Abstract][Full Text] [Related]
35. Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms.
Swenson JM; Williams PP; Killgore G; O'Hara CM; Tenover FC
J Clin Microbiol; 2001 Oct; 39(10):3785-8. PubMed ID: 11574619
[TBL] [Abstract][Full Text] [Related]
36. Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method.
Satola SW; Farley MM; Anderson KF; Patel JB
J Clin Microbiol; 2011 Jan; 49(1):177-83. PubMed ID: 21048008
[TBL] [Abstract][Full Text] [Related]
37. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
Staneck JL; Glenn S; DiPersio JR; Leist PA
J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
[TBL] [Abstract][Full Text] [Related]
38. Erroneous reporting of vancomycin susceptibility for Staphylococcus spp. by Vitek software version 2.01.
Behera B; Mathur P
Jpn J Infect Dis; 2009 Jul; 62(4):298-9. PubMed ID: 19628909
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial susceptibility testing of vancomycin-resistant Enterococcus by the VITEK 2 system, and comparison with two NCCLS reference methods.
Kobayashi I; Muraoka H; Iyoda T; Nishida M; Hasegawa M; Yamaguchi K
J Med Microbiol; 2004 Dec; 53(Pt 12):1229-1232. PubMed ID: 15585502
[TBL] [Abstract][Full Text] [Related]
40. Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.
Kosowska-Shick K; Clark C; Pankuch GA; McGhee P; Dewasse B; Beachel L; Appelbaum PC
Antimicrob Agents Chemother; 2009 Oct; 53(10):4217-24. PubMed ID: 19620338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
